PLA2G2A and metabolic dysfunction-associated steatotic liver disease: We analyzed other RNA-seq data in normal, nonalcoholic fatty liver disease, and steatohepatitis tissues and it indicated that PLA2G2A mRNA expression was not significantly enhanced in pathological liver tissues with the possibility of being pre-cancerous.